Proacta Company
Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.
Technology:
Others
Industry:
PharmTech
Headquarters:
La Jolla, California, United States
Founded Date:
2004
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
7
Total Funding:
$47M
Last Funding Type:
Debt Financing
Register and Claim Ownership